Q1 saw a temporary margin dip due to input cost spikes, but operations and profitability normalized by mid-quarter. Revenue grew 35% year-over-year, with strong cash flow and strategic progress in specialty and B2C segments. Management maintains 20% growth guidance for FY27.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.